Skip to content

Artificial Intelligence and Bowel Cleansing Quality

Design and Validation of an Artificial Intelligence System to Detect the Quality of Colon Cleansing Before Colonoscopy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05553977
Acronym
CALPER2
Enrollment
667
Registered
2022-09-26
Start date
2022-10-01
Completion date
2023-05-30
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleansing Quality of the Colon

Keywords

Bowel cleansing, Colonoscopy, Convolutional Neural Network

Brief summary

The main purpose of the study is to design and validate a convolutional neural network (CNN) with the ability to discriminate between pictures of effluents with different qualities of bowel cleansing and in a second time to prospectively assess in a cohort of patients the agreement between the result of the last rectal effluent quality assessed by the CNN and the cleansing quality assessed during the colonoscopy assessed by a validated scale (Boston Bowel Preparation Scale, BBPS). Patients will be prepared with polyethylene glycol (PEG), PEG plus ascorbic acid (PEG-Asc) or sodium picosulfate-oxide magnesium solution (PS).

Detailed description

The patient perception of the last bowel movement before the colonoscopy has been shown a powerful predictor of bowel cleansing rated during colonoscopy. A large study involving 1011 patients distributed in a derivation cohort (633 patients) and a validation cohort (378 patients) using a set of 4 pictures resembling bowel cleansing qualities showed a moderate agreement with the BBPS. In addition, a good agreement was found when the staff perception and patient perception of the last bowel movement were compared. These findings offer an excellent opportunity to test rescue cleansing interventions the same day of the examination, before colonoscopy. Over the last two years, artificial intelligence applications have wrought a substantial breakthrough in several disciplines, including endoscopy. Machine learning and its more advanced form deep learning, refers to the development of algorithms (convolutional neural networks) with the ability to learn and perform certain tasks. In the endoscopy setting, computer vision applications have been stated as research priority field. Based on all this experience, the aim of this study was to design and to validate a convolutional neural network capable of automatically predicting the quality of the patient cleansing at home after the intake of the bowel cleansing solution and before attending the colonoscopy. The other aim was to prospectively assess in a cohort of patients the agreement between the result of the last rectal effluent quality assessed by the convolutional neural network and the cleansing quality assessed during the colonoscopy assessed by a validated scale (Boston Bowel Preparation Scale, BBPS) This study is nested in an observational prospective study conducted at the Open Access Endoscopy Unit of the Hospital Universitario de Canarias between February 2021 and May 2021 (NCT04702646). A total of 633 consecutive outpatients with a scheduled colonoscopy participated in this study (a total of 266 patients (42%) sent at least one picture). After this study, patients in whom an outpatient colonoscopy was requested, were asked to provide pictures of their effluents during bowel preparation intake. A subgroup of these images will be classified by the personal of our unit in adequate and inadequate and will be used to train the convolutional neural network. Another set of images will be used to validate the convolutional neural network. Additionally, the investigators will validate in-vivo the convolutional neural network comparing its classification of the effluent quality with a validated colon cleansing scale during the colonoscopy.

Interventions

DRUGBowel preparation for colonoscopy

one day liquid diet will be administered to every patient included in the study and: split-dose bowel preparation with 4 Liters of Polyethylene glycol solution, 2 Liters of PEG-Ascorbic acid or 2 Liters Picosulfate.

PROCEDUREColonoscopy

Colonoscopy will be performed to every patient included in the study

Sponsors

Hospital Universitario de Canarias
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18, to sign the informed consent, * Patients with indication of outpatient colonoscopy * Patients ingesting the bowel preparation

Exclusion criteria

* Incomplete colonoscopy (except for poor bowel preparation) * Contraindication for colonoscopy * Allergies. * Refusal to participate in the study or impairment to sign the informed consent. * Colectomy (more than 1 segment) * Dementia with difficulty in the intake of the preparation

Design outcomes

Primary

MeasureTime frameDescription
Effluent characteristics1 yearEffluent characteristics. Set of 4 pictures categorized in adequate preparation (clear liquid, clear liquid with lumps) and inadequate preparation (dark liquid, or dark liquid with solid particles). The concolutional Neural Network will be trained with effluent images and validated.
Quality of bowel cleansing assessed by the Boston Bowel Preparation Scale1 yearsQuality of bowel cleansing assessed by the Boston Bowel Preparation Scale. This scale goes from 0 (no preparation) to 3 points (excellent preparation) in the three segments of the colon (proximal, transverse and distal). The maximum score is 9 points

Countries

Spain

Contacts

Primary ContactAntonio Z Gimeno García, MD, PhD
antozeben@gmail.com+34922678554

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026